Trials / Active Not Recruiting
Active Not RecruitingNCT06515743
Rehabilitation With an Obturator in Maxillary Defects
Comparison of Quality of Life After Rehabilitation With an Obturator in Maxillary Defects Due to COVID-19 Associated Mucormycosis and Oral Cancer.
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- —
Summary
During the COVID-19 pandemic, there was a lot of reporting of COVID-19-associated mucormycosis cases. Managing this condition posed a new challenge to clinicians. Management includes therapeutic drugs and aggressive surgical debridement. Due to the unpredictability of disease prognosis and the possible recurrence of the disease, rehabilitation with delayed surgical obturators is beneficial for patients. Hence, the current study aimed to evaluate the impact of delayed surgical obturators on quality of life of COVID-19-associated mucormycosis patients post-maxillectomies
Detailed description
Globally, the prevalence of mucormycosis varied from 0.005 to 1.7 per million population, while its prevalence is nearly 80 times higher (0.14 per 1000) in India compared to developed countries, in a recent estimate of year 2019-2020. Among the medical professionals involved in managing patients with mucormycosis, maxillofacial prosthodontists are responsible for prosthetic restoration of lost oral and maxillofacial structures, helping patients to socialize and have an acceptable quality of life after surgical treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Delayed surgical obturator | Prosthetic rehabilitation after surgical treatment of mucormycosis is essential for the early restoration of oral function and facial esthetics which is performed by using the surgical obturator. |
Timeline
- Start date
- 2024-02-04
- Primary completion
- 2024-09-20
- Completion
- 2024-11-30
- First posted
- 2024-07-23
- Last updated
- 2024-08-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06515743. Inclusion in this directory is not an endorsement.